Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome is a rare but critical disease with a high mortality rate. The diagnostic dilemma of PPP syndrome is the fact that symptoms occur unexpectedly. A 48-year-old man presented with fever and painful swelling of the left foot that was initially mistaken for cellulitis and gouty arthritis. The diagnosis of PPP syndrome was made based on the abdominal CT findings and elevated pancreatic enzyme levels, lobular panniculitis with ghost cells on a skin biopsy, and polyarthritis on a bone scan. The pancreatitis and panniculitis disappeared spontaneously over time, but the polyarthritis followed its own course despite the use of anti-inflammatory agents. In addition to this case, 30 cases of PPP syndrome in the English literature were reviewed. Most of the patients had initial symptoms other than abdominal pain, leading to misdiagnosis. About one-third of them were finally diagnosed with a pancreatic tumor, of which pancreatic acinar cell carcinoma was the most dominant. They showed a mortality rate of 32.3%, associated mainly with the pancreatic malignancy. Therefore, PPP syndrome should be considered when cutaneous or osteoarticular manifestations occur in patients with pancreatitis. Active investigation and continued observations are needed for patients suspected of PPP syndrome. (Korean J Gastroenterol 2019;74:175-182) 
INTRODUCTION
Chiari first reported the association of pancreatitis with panniculitis in 1883. 1 Pancreatic panniculitis is a rare complication that occurs in approximately 2-3% of patients with pancreatic diseases, mainly pancreatitis. 2 Less frequently, these patients may also show polyarthritis, the combination of which is referred to as pancreatitis, panniculitis, and polyarthritis (PPP) syndrome. 3 Pancreatitis, panniculitis, and polyarthritis, the triad of PPP syndrome, can occur synchronously, but one may precede the others. For this reason, panniculitis can be mistaken for erythema nodosum or subcutaneous abscess, whereas joint involvement can be mistaken for septic arthritis, crystal-induced arthropathy, or rheumatoid arthritis.
The prognosis of patients with PPP syndrome usually depends on the underlying pancreatic disorder. A delay in the diagnosis and treatment of the underlying pancreatic disease worsens the clinical outcomes, which can result in a mortality rate as high as 24%. drome that was initially mistaken for cellulitis and gouty arthritis, along with a review of the English literature.
CASE REPORT
A 48-year-old man presented to the emergency room with a 7-day history of fever and painful swelling of the left foot.
The patient also complained of mild epigastric pain that occurred three weeks prior. He had continued to drink alcohol (mean 188 g/day) after suffering from pancreatitis at 18 months earlier. The patient was also a 30-pack-year smoker.
He had no history of diabetes or hypertension.
At the time of the initial presentation, the patient had a blood pressure of 110/70 mmHg, pulse rate of 114 beats/min, respiratory rate of 20 breaths/min, and temperature of 38.1℃.
Epigastric and periumbilical tenderness were evident upon palpation. The erythematous swelling on the left foot was combined with tenderness and a decreased range of motion.
Tender, erythematous nodules were observed in both pretibial regions ( Fig. 1 ).
The laboratory tests showed a white blood cell count of 24,200/μL (reference range, 3,800-10,000), hemoglobin level of 11.9 g/dL (13.3-16.5), platelet count of 205×10 A technetium-99m hydroxymethylene diphosphonate bone scan showed symmetrical uptake in the foot, hand, wrist, and elbow joints (Fig. 6) . The blood tests for rheumatoid arthritis were negative. Ultrasound-guided aspiration of the left first metatarsophalangeal joint yielded a dry tap, i.e., failure to aspirate synovial fluid. As a result, samples could not be obtained for analysis. Finally, a diagnosis of PPP syndrome was made based on the chronic pancreatitis on abdominal CT, mostly lobular panniculitis and adipocyte necrosis on a skin biopsy, and polyarthritis on a bone scan. 
LITERATURE REVIEW
English articles published between September 2009 and January 2019 were reviewed using the key words "pancreatitis", "panniculitis", and "arthritis". A total of 30 cases of PPP syndrome were identified in the English literature. An early diagnosis of PPP syndrome is difficult when joint involvement or panniculitis dominate with a few symptoms of pancreatitis or vice versa. A delay in the diagnosis and treatment of the underlying pancreatitis can result in significant mortality. 33, 34 In addition, osteoarticular involvement in PPP syndrome can cause permanent destruction, leading to significant morbidity.
The pathogenesis of panniculitis and joint involvement in PPP syndrome is not well known. The most accepted hypothesis is fat necrosis caused by pancreatic lipolytic enzymes. 35 In PPP syndrome, subcutaneous fat necrosis causes pancreatic panniculitis, mainly in the lower extremities. The clinical or histology findings of pancreatic panniculitis may vary according to the disease duration. Acute lesions usually appear as subcutaneous nodules (0.5-5 cm in diameter) and histologically lobular panniculitis with necrosis of adipocytes ("ghost cells"), which is pathognomonic for pancreatic panniculitis and is subsequently replaced with granulomatous infiltration over time. 2 In this case, a histology examination of the pretibial skin lesions revealed mostly lobular panniculitis and adipocyte necrosis.
Osteoarticular involvement of PPP syndrome includes arthritis, serositis, or periarticular or intramedullary fat necrosis. 15 In patients with PPP syndrome, arthritis can come from either periarticular fat necrosis or direct extension from the subcutaneous fat necrosis to the adjacent joint space. 36 Most joint involvement is polyarticular, involving mainly the foot, ankle, hand, or wrist joints. Aspiration of the involved joint fluid shows viscous and creamy to yellowish material on the gross appearance, positively birefringent lipid crystals or fat globules with a few cellular components on microscopy, and a high lipid content for cholesterol and triglyceride in a lipid analysis. 35 In PPP syndrome, joint involvement usually follows its own course, without any response to treatment with an NSAID, steroid, or immunosuppressant. In this case, the foot, hand, wrist, and elbow joints were symmetrically involved. Aspiration of the involved joint yielded a dry tap with no crystals on microscopy. The pancreatitis and panniculitis improved spontaneously with time, but the polyarthritis waxed and waned regardless of the long-term use of colchicine, an NSAID, a steroid, or octreotide.
In a review of the literature, most patients with PPP syndrome presented with chief complaints other than symptoms of pancreatitis, such as abdominal pain. Therefore, the clinician focused more on the chief complaints rather than considering their association with pancreatitis, making it easier to misdiagnose them as another disorder. In the present case, the patient presented with painful swelling of the left foot that was initially mistaken for cellulitis and then misdiagnosed as gouty arthritis. As a result, the patient was treated with colchicine, an NSAID, and a low-dose steroid for a long time.
The findings show that PPP syndrome should be considered when extrapancreatic manifestations, such as arthralgia or skin lesions occur in patients with pancreatitis.
In addition to acute or chronic pancreatitis, pancreatic cancer or pseudocysts may be associated with PPP syndrome.
In a previous review, the mortality rate of PPP syndrome was high at 24%. 3 The review revealed a mortality rate of 30.0%.
Interestingly, more than 30% of the patients with PPP syndrome were finally diagnosed with a pancreatic neoplasm, 80% of whom died. In these patients, the pancreatic cancer was more likely to be the underlying cause of PPP syndrome than pancreatitis. In the review, the mortality rate was highest in patients with PPP syndrome who were finally diagnosed with a pancreatic neoplasm, of which pancreatic acinar cell carcinoma was most common. Although pancreatic acinar cell carcinoma accounts for approximately 1% of all pancreatic tumors, 37 it is the most common pancreatic neoplasm causing PPP syndrome. Therefore, PPP syndrome can be considered as a surrogate marker for pancreatic diseases with poor outcomes. In addition, patients with long-standing PPP syndrome require careful monitoring for the possibility of pancreatic cancers, such as acinar cell carcinoma.
In conclusion, clinicians should include PPP syndrome in a differential diagnosis when extrapancreatic manifestations, such as osteoarticular involvement or subcutaneous nodules occur in patients with pancreatic disorder(s). Considering the high mortality rate and possibility of a hidden pancreatic malignancy in patients with PPP syndrome, continuous surveillance and active investigation are needed to improve the clinical outcomes.
